Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
50 Cards in this Set
- Front
- Back
highest control over the ANS
|
hypothalamus
regulates complex integration of multiple systems |
|
cerebral cortex and limbic system influence....
|
hypothalamus and brainstem directly or indirectly
|
|
somatic nervous system is a ____ ganglion system and ANS is a ____ ganglion system
|
one; two
|
|
SNS: synapses at ____
ANS: synapses at ____ |
neuromuscular junction
target organ |
|
SNS has ____ type of transmitter and receptor
ANS has ____ type of transmitter and receptor |
one
multiple |
|
Parasympathetic Autonomic Nervous System properties
|
rest and digest, neurons originate in the brainstem/sacral spinal cord, long preganglionic/short postganglionic, very specific responses to innervation, innervates viscera of organs
targets: GI, heart, eye, genitalia, excretory organs, exocrine glands |
|
Sympathetic Autonomic Nervous System properties
|
fight or flight, energy consuming, neurons originate in T-spine, short preganglionic/long postganglionic, one neuron innervates many cells, selective responses, activation or inhibition of organ
targets: cardiovascular system, metabolic organs, lungs, smooth muscles, some glands (sweat) |
|
Which ANS: decrease heart rate
|
PANS
|
|
Which ANS: increases GI peristalsis
|
PANS
|
|
Which ANS: stimulates urination and defecation
|
PANS
|
|
Which ANS: increases glandular secretions
|
PANS (ex salivation, lacrimation)
|
|
Which ANS: constricts pupils and accommodates
|
PANS
|
|
Which ANS: contracts smooth muscles and bronchioles
|
PANS
|
|
Which ANS: increases heart rate, respiration, blood pressure
|
SANS
|
|
Which ANS: increase blood supply to heart, lungs, brain
|
SANS
|
|
Which ANS: reduces blood supply to viscera
|
SANS
|
|
Which ANS: bronchodilates
|
SANS
|
|
Which ANS: dilates the pupil
|
SANS
|
|
Which ANS: regulates glycogenolysis, gluconeogenesis, lipolysis
|
SANS
|
|
Which ANS: secretes renin
|
SANS
|
|
Sweat glands
|
anatomically sympathetic, stimulated by ACh at axonal terminal (cholinergic)
|
|
chromaffin cells
|
preganglionic sympathetic cells in adrenal medulla, innvervated by ACh, release EPI/NE into blood stream
|
|
Acetylcholine
|
cholinergic neuro transmitter. released into synaptic cleft, broken down by acetylcholinesterase (AChE)
|
|
botulinum toxin
|
blocks exocytosis of ACh by cleaving SNARE proteins
|
|
ACh Synthesis
|
uptake of choline into axon terminal by Na+ and carrier protein (RATE LIMITING STEP), acetyl CoA + choline -> ACh, CoA, H2O
|
|
ACh Storage
|
ACh Vesicular Uptake, transported by VAT (carrier protein)
|
|
ACh Release
|
Vesicle Fusion, action potential opens Ca2+ channels which mediates fusion of vesicle to membrane, SNARE/VAMP/SNAP proteins mediate fusion/exocytosis
|
|
hemicholinium
|
inhibits ACh synthesis
|
|
vesamicol
|
depletes ACh stores in vesicles
|
|
ACh termination/degradation
|
ACh terminated by AChE (indirct cholinergic agonist), choline is recycled
|
|
Postsynaptic effects of ACh
|
ACh binds to muscarinic/nicotinic receptors, mimcs effects of muscarine and nicotine
|
|
Dopamine (DA)
|
main trasmitter of extrapyramidal system
|
|
Norepinephrine (NE)
|
or noradrenaline, released from most postganglionic sympathetic neurons and CNS
|
|
Epinephrine (EPI)
|
or adrenaline, major hormone released from adrenal medula
|
|
Adrenergic neurotransmitter synthesis (endogenous catacholamines)
|
Tyrosine -> DOPA -> DA -> NE -> EPI
|
|
NE synthesis/storage
|
uptake of tyrosine, converted to DOPA by tyrosine hydroxylase (RATE LIMITING), DOPA -> DA by DOPA decarboxylase, DA transported to vesicle, DA -> NE by dopamine β-hydroxylase
|
|
Metyrosine
|
blocks catacholamine synthesis by inhibiting tyrosine hydroxylase
|
|
Reserpine
|
blocks transportation of DA to vesicles
|
|
NE release
|
ACh binds to nicotinic neuronal receptors and elicits AP, Ca2+ channels trigger exocytosis + ATP/peptides
|
|
Amphetamines/tyramine
|
displace NE from vesicle and cause release
|
|
guanethidine/guanadrel
|
block release of NE
|
|
NE Termination/Degradation
|
terminated primarily by reuptake into terminal by NE transporter (NET, Uptake-1), stored in vesicles
|
|
Monoamine oxidase (MAO)
|
metabolizes DA and NE in cytoplasm
|
|
cocaine/tricyclic antidepressants
|
inhibit Uptake-1, increase effects of NE in synaptic cleft
|
|
Epinephrine synthesis
|
synthesized in chromaffin cells, specifc chromaffin cell type contains phenylethylanomine N-methyltransferase (PNMT), NE -> EPI by PNMT, corticosteroids increase synthesis of PNMT (ex: stress)
|
|
Autoreceptors
|
presynaptic receptors that respond to neurotransmitters to modify its own synthesis and release
ex: ACh binds to M2/M4 receptors and inhibit ACh release |
|
Heteroreceptors
|
presynaptic receptors that respond to neurotransmitters released by adjacent cells, integrates two systems
ex: parasymp postgang cholinergic receptors have α2 receptors activated by NE that inhibit ACh release and the effects of PANS |
|
Cardiovascular autonomic reflex
|
baroreceptor reflex: stretch/baroceptor receptors in walls of major arteries respond to blood pressure; increased stretch=increased BP, signal to brainstem inhibit SANS and stimulate PANS
|
|
GI autonomic reflex
|
full colon stimulates stretch receptors, impulses to spinal cord, PANS increases peristalsis = defecation
|
|
Urinary bladder autonomic reflex
|
full bladder stretches, impulse to spinal cord, PANS contracts bladder and relaxes sphincter = urination
|